Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder
Autore:
Mavissakalian, MR; Schmier, JK; Flynn, JA; Revicki, DA;
Indirizzi:
Case Western Reserve Univ, Dept Psychiat, Cleveland, OH USA Case Western Reserve Univ Cleveland OH USA t Psychiat, Cleveland, OH USA Louis Stokes VAMC, Cleveland, OH USA Louis Stokes VAMC Cleveland OH USALouis Stokes VAMC, Cleveland, OH USA MEDTAP Int, Ctr Hlth Outcomes Res, Bethesda, MD USA MEDTAP Int Bethesda MD USA Int, Ctr Hlth Outcomes Res, Bethesda, MD USA
Titolo Testata:
PHARMACOECONOMICS
fascicolo: 4, volume: 18, anno: 2000,
pagine: 383 - 391
SICI:
1170-7690(200010)18:4<383:CEOAIT>2.0.ZU;2-Z
Fonte:
ISI
Lingua:
ENG
Soggetto:
DOUBLE-BLIND; RECURRENT DEPRESSION; COGNITIVE THERAPY; ECONOMIC BURDEN; AGORAPHOBIA; PLACEBO; EXPOSURE; DISCONTINUATION; FLUVOXAMINE; PAROXETINE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
37
Recensione:
Indirizzi per estratti:
Indirizzo: Mavissakalian, MR Univ Hosp Cleveland, Anxiety Disorders Program, 11100 Euclid Ave, Cleveland, OH 44106 USA Univ Hosp Cleveland 11100 Euclid Ave Cleveland OH USA 44106
Citazione:
M.R. Mavissakalian et al., "Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder", PHARMACOECO, 18(4), 2000, pp. 383-391

Abstract

Objective: To examine the medical costs and effectiveness of acute treatment with imipramine versus acute treatment plus 2 different maintenance therapies for panic disorder. Methods: A clinical decision model was constructed to estimate 18-month costs and outcomes associated with these treatment scenarios based on the medical literature and clinician judgment. The clinical parameters and outcomes for the model were derived from a series of systematic clinical trials with imipramine utilising uniform dosage procedures and validated response criteria. Costs were calculated based on standardised treatment regimens. Theoutcome measures were 18-month medical costs, quality-adjusted life years (QALYs) and costs per QALY gained. A sensitivity analysis was performed to explore the impact of treatment withdrawals on outcomes. Study perspective: US mental healthcare system. Results: Over 18 months, the total costs (1997 values) and QALYs associated with half-dose maintenance therapy (imipramine 1.1 mg/kg/day) [$US3377; QALYs = 0.991] and full-dose maintenance therapy (imipramine 2.25 mg/kg/day)[$US3361; QALYs = 0.991] were almost identical; both were cost saving compared with acute imipramine therapy (2.25 mg/kg/day) with no maintenance treatment ($US3691 : QALYs = 0.979). Whether patients withdrawing from treatment were considered to have continued to respond to treatment or to have relapsed, the half-dose and full-dose maintenance treatments were still cost saving compared with acute treatment alone. Conclusions: The results indicate that imipramine maintenance treatment iscost effective compared with acute imipramine treatment for patients with panic disorder. The basic findings and conclusions are not affected after modifying model assumptions for clinical response in patients withdrawing from treatment.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 15:12:18